S Thoelen

1.2k total citations
18 papers, 816 citations indexed

About

S Thoelen is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, S Thoelen has authored 18 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in S Thoelen's work include Hepatitis B Virus Studies (13 papers), Hepatitis Viruses Studies and Epidemiology (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). S Thoelen is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Hepatitis Viruses Studies and Epidemiology (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). S Thoelen collaborates with scholars based in Belgium, Netherlands and Switzerland. S Thoelen's co-authors include Pierre Van Damme, Assad Safary, A. Meheus, Geert Leroux‐Roels, Isabelle Desombere, Catharina Matheï, Katya De Groote, M. Slaoui, Pierre Vandepapelière and A Leentvaar-Kuypers and has published in prestigious journals such as Hepatology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

S Thoelen

18 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Thoelen Belgium 10 506 467 251 185 96 18 816
Francis J. Mahoney United States 16 744 1.5× 504 1.1× 163 0.6× 53 0.3× 47 0.5× 22 976
Staffan Sylvan Sweden 16 410 0.8× 230 0.5× 174 0.7× 114 0.6× 45 0.5× 55 603
Thanunrat Thongmee Thailand 18 278 0.5× 111 0.2× 550 2.2× 65 0.4× 133 1.4× 54 836
Loïc Chartier France 17 386 0.8× 107 0.2× 503 2.0× 131 0.7× 106 1.1× 23 893
Feng‐Yee Chang Taiwan 13 434 0.9× 179 0.4× 249 1.0× 33 0.2× 72 0.8× 40 704
M Mounier France 16 253 0.5× 104 0.2× 250 1.0× 138 0.7× 49 0.5× 45 776
F Ambrosch Austria 16 545 1.1× 415 0.9× 261 1.0× 154 0.8× 90 0.9× 51 811
Christopher J. Harrison United States 21 659 1.3× 83 0.2× 375 1.5× 188 1.0× 62 0.6× 49 1.1k
Mazyar Ziyaeyan Iran 18 508 1.0× 126 0.3× 376 1.5× 36 0.2× 188 2.0× 71 905
Veronik Hutse Belgium 17 644 1.3× 214 0.5× 302 1.2× 137 0.7× 64 0.7× 43 932

Countries citing papers authored by S Thoelen

Since Specialization
Citations

This map shows the geographic impact of S Thoelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Thoelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Thoelen more than expected).

Fields of papers citing papers by S Thoelen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Thoelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Thoelen. The network helps show where S Thoelen may publish in the future.

Co-authorship network of co-authors of S Thoelen

This figure shows the co-authorship network connecting the top 25 collaborators of S Thoelen. A scholar is included among the top collaborators of S Thoelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Thoelen. S Thoelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Frenck, Robert W., John Ervin, Laurence Chu, et al.. (2019). Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial. The Lancet Infectious Diseases. 19(6). 631–640. 57 indexed citations
2.
Smith, William B., Darren Abbanat, Bart Spiessens, et al.. (2019). 2712. Safety and Immunogenicity of two Doses of ExPEC4V Vaccine Against Extraintestinal Pathogenic Escherichia coli Disease in Healthy Adult Participants. Open Forum Infectious Diseases. 6(Supplement_2). S954–S954. 7 indexed citations
3.
4.
Jacques, P, Guido Moens, Isabelle Desombere, et al.. (2002). The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. Vaccine. 20(31-32). 3644–3649. 66 indexed citations
5.
Thoelen, S. (2000). An overview on a novel adjuvanted prophylactic hepatitis B vaccine.. PubMed. 63(2). 185–6. 5 indexed citations
6.
Dagan, Ron, et al.. (2000). Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. The Pediatric Infectious Disease Journal. 19(11). 1045–1052. 98 indexed citations
7.
Ambrosch, F, G Wiedermann, Michael Kundi, et al.. (2000). A hepatitis B vaccine formulated with a novel adjuvant system. Vaccine. 18(20). 2095–2101. 55 indexed citations
8.
Jacques, P, Guido Moens, Isabelle Desombere, et al.. (1999). A hepatitis B vaccine with a novel adjuvant: immunogenicity and reactogenicity profile in adult vaccine nonresponders. 39. 373. 3 indexed citations
9.
Thoelen, S, Pierre Van Damme, A Leentvaar-Kuypers, et al.. (1999). The first combined vaccine against hepatitis A and B: an overview. Vaccine. 17(13-14). 1657–1662. 105 indexed citations
10.
Herck, Koen Van, Pierre Van Damme, S Thoelen, & A. Meheus. (1998). Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results. Vaccine. 16(20). 1933–1935. 44 indexed citations
11.
Bertino, Joseph, S Thoelen, Pierre Van Damme, et al.. (1998). A Dose Response Study of Hepatitis A Vaccine in Healthy Adults Who Are ≥30 Years Old and Weigh ≥77 kg. The Journal of Infectious Diseases. 178(4). 1181–1184. 6 indexed citations
12.
Thoelen, S, Pierre Van Damme, Catharina Matheï, et al.. (1998). Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system. Vaccine. 16(7). 708–714. 128 indexed citations
13.
Damme, Pierre Van, Koen Van Herck, S Thoelen, & A. Meheus. (1998). Long-term immunogenicity of a high potency inactivated hepatitis A vaccine. Journal of Hepatology. 28. 113–113. 2 indexed citations
14.
Thoelen, S, et al.. (1996). Immunogenicity of a combined hepatitis A and hepatitis B vaccine in healthy adults. Hepatology. 23(1). 5 indexed citations
15.
Damme, Pierre Van, et al.. (1996). Safety and Immunogenicity of a High–Potency Inactivated Hepatitis A Vaccine. Journal of Travel Medicine. 3(2). 83–90. 7 indexed citations
16.
Damme, Pierre Van, et al.. (1994). Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long‐term antibody persistence. Journal of Medical Virology. 44(4). 446–451. 132 indexed citations
17.
Damme, Pierre Van, Catharina Matheï, S Thoelen, et al.. (1994). Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity. Journal of Medical Virology. 44(4). 435–441. 76 indexed citations
18.
Thoelen, S, et al.. (1993). The safety, reactogenicity and longterm immunogenicity of two lots of an inactivated hepatitis A vaccine. 156–160. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis J. Mahoney Breakdown of academic impact, for papers by Staffan Sylvan Breakdown of academic impact, for papers by Thanunrat Thongmee Breakdown of academic impact, for papers by Loïc Chartier Breakdown of academic impact, for papers by Feng‐Yee Chang Breakdown of academic impact, for papers by M Mounier Breakdown of academic impact, for papers by F Ambrosch Breakdown of academic impact, for papers by Christopher J. Harrison Breakdown of academic impact, for papers by Mazyar Ziyaeyan Breakdown of academic impact, for papers by Veronik Hutse
Rankless by CCL
2026